Back

Atrial fibrillation in hypertrophic cardiomyopathy: clinical implications of an early detection through implanted cardioverter defibrillator

26 August 2018 (12:00 - 12:15)
Organised by:
Congress Presentation Part of: Atrial fibrillation in hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Riccardo Morgagni

Tor Vergata University Hospital Polyclinic, Rome (Italy)

5 More presentations in this session

Presentation thumbnail
Efficacy and safety of non-vitamin K oral anticoagulants in hypertrophic cardiomyopathy with non-valvular atrial fibrillation: a nationwide cohort study
Doctor P. Yang (Seongnam, KR)
Abstract Slides Video
Presentation thumbnail
Left atrial remodelling in hypertrophic cardiomyopathy, contributing factors and associated outcomes
Doctor S. Cuddy (Boston, US)
Abstract Slides Video
Presentation thumbnail
Impact of left atrial enlargement on very long-term outcomes in patients with hypertrophic cardiomyopathy
Doctor Y. Azumi (Kobe, JP)
Abstract
Presentation thumbnail
Is atrial fibrillation associated with increased mortality in hypertrophic cardiomyopathy? Results from the portuguese registry.
Doctor A. Lebreiro (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study.
Doctor A. Foa' (Bologna, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation in hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2018

26 August 2018 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Hypertrophic cardiomyopathy and atrial fibrillation: the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology
29 August 2022
thumbnail
Webinar
Diagnosis and management of hypertrophic cardiomyopathy
5 December 2023
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation
31 March 2025
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator implantation should be considered in high-risk patients with apical hypertrophic cardiomyopathy as the same manner with the septal type
18 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources